Meropol Neal J, Schulman Kevin A
Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
J Clin Oncol. 2007 Jan 10;25(2):180-6. doi: 10.1200/JCO.2006.09.6081.
Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.
在大多数临床医学领域,医疗技术的成本越来越高。肿瘤学也未能幸免与成本相关的问题,部分原因是巨大的科学进步带来了用于患者诊断、治疗和随访的新工具。总体医疗保健成本(尤其是癌症治疗成本)的不断上升引发了与其对我们的经济和社会公民的影响相关的复杂问题。本文回顾了支配医疗支出的宏观经济原则和个人行为,并探讨了成本如何对不同人群产生不成比例的影响。我们的总体目标是围绕影响肿瘤临床实践的卫生政策问题展开辩论。